CEBPB and cancer: MDSCs are immature myeloid immune cells that display an immunosuppressive phenotype in cancer [42,43] that is driven by molecular mechanisms, including signaling pathways induced by kinases AMPK, Akt, and ERK [28,29], and transcription factors such as C/EBP-β [31,32].